Vaxart Analyst Ratings
Vaxart Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/07/2023 | 400% | Cantor Fitzgerald | → $4 | Reiterates | Overweight → Overweight |
| 08/07/2023 | 400% | Cantor Fitzgerald | $6 → $4 | Maintains | Overweight |
| 12/19/2022 | 87.5% | B. Riley Securities | $6 → $1.5 | Maintains | Neutral |
| 09/02/2022 | 900% | Cantor Fitzgerald | $11 → $8 | Maintains | Overweight |
| 05/19/2022 | 650% | B. Riley Securities | $7 → $6 | Maintains | Neutral |
| 11/02/2021 | 1775% | Cantor Fitzgerald | → $15 | Initiates Coverage On | → Overweight |
| 06/30/2021 | 1025% | B. Riley Securities | $13 → $9 | Downgrades | Buy → Neutral |
| 06/24/2021 | 1525% | Jefferies | → $13 | Initiates Coverage On | → Buy |
| 06/11/2021 | 2150% | Piper Sandler | → $18 | Initiates Coverage On | → Overweight |
| 08/12/2020 | 2025% | HC Wainwright & Co. | $7 → $17 | Maintains | Buy |
| 07/13/2020 | 2650% | B. Riley Securities | → $22 | Initiates Coverage On | → Buy |
| 04/30/2020 | 775% | HC Wainwright & Co. | $3 → $7 | Reiterates | → Buy |
| 06/27/2019 | 150% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/07/2023 | 400% | 康託·菲茨傑拉德 | →$4 | 重申 | 超重→超重 |
| 08/07/2023 | 400% | 康託·菲茨傑拉德 | $6→$4 | 維護 | 超重 |
| 2022年12月19日 | 87.5% | B.萊利證券 | $6→$1.5 | 維護 | 中性 |
| 09/02/2022 | 900% | 康託·菲茨傑拉德 | $11→$8 | 維護 | 超重 |
| 2022年05月19日 | 650% | B.萊利證券 | $7→$6 | 維護 | 中性 |
| 11/02/2021 | 1775% | 康託·菲茨傑拉德 | →$15 | 開始承保 | →超重 |
| 2021/06/30 | 1025% | B.萊利證券 | $13→$9 | 評級下調 | 購買→中性 |
| 06/24/2021 | 1525% | 傑富瑞 | →$13 | 開始承保 | →購買 |
| 2021/11/06 | 2150% | 派珀·桑德勒 | →$18 | 開始承保 | →超重 |
| 2020年08月12日 | 2025% | HC Wainwright公司 | $7→$17 | 維護 | 買 |
| 07/13/2020 | 2650% | B.萊利證券 | →$22 | 開始承保 | →購買 |
| 04/30/2020 | 775% | HC Wainwright公司 | $3→$7 | 重申 | →購買 |
| 2019年06月27日 | 150% | HC Wainwright公司 | →$2 | 開始承保 | →購買 |
What is the target price for Vaxart (VXRT)?
Vaxart(VXRT)的目標價是多少？
The latest price target for Vaxart (NASDAQ: VXRT) was reported by Cantor Fitzgerald on September 7, 2023. The analyst firm set a price target for $4.00 expecting VXRT to rise to within 12 months (a possible 400.00% upside). 3 analyst firms have reported ratings in the last year.
康託·菲茨傑拉德於2023年9月7日報道了瓦克薩(納斯達克代碼：VXRT)的最新目標價。這家分析公司將目標價定為4美元，預計VXRT將在12個月內上漲至(可能上漲400.00%)。3家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Vaxart (VXRT)?
Vaxart(VXRT)最近的分析師評級是多少？
The latest analyst rating for Vaxart (NASDAQ: VXRT) was provided by Cantor Fitzgerald, and Vaxart reiterated their overweight rating.
納斯達克(Sequoia Capital：VXRT)的最新分析師評級由康託·菲茨傑拉德提供，Vaxart重申其增持評級。
When is the next analyst rating going to be posted or updated for Vaxart (VXRT)?
Vaxart(VXRT)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxart was filed on September 7, 2023 so you should expect the next rating to be made available sometime around September 7, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查看公開的財務報表，與Vaxart的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。對Vaxart的上一次評級是在2023年9月7日提交的，因此您應該預計下一次評級將在2024年9月7日左右提供。
Is the Analyst Rating Vaxart (VXRT) correct?
分析師評級Vaxart(VXRT)正確嗎？
While ratings are subjective and will change, the latest Vaxart (VXRT) rating was a reiterated with a price target of $0.00 to $4.00. The current price Vaxart (VXRT) is trading at is $0.80, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Vaxart(VXRT)評級被重申，目標價在0.00美元至4.00美元之間。Vaxart(VXRT)目前的交易價格為0.80美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。